Regeneron's CD20xCD3 bispecific antibody for non-Hodgin lymphoma (NHL) has been approved in Europe, five months after it was turned down by the FDA in the US. Ordspono (odronextamab) has been ...

A high-level overview of CHAR Technologies Ltd. (YES:CA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

This repository contains the source code for a profane content filter 🤬. The GitHub Action: Profane content filter maintains over 4,900 swear words from nine different languages. For a list of all ...